Gunnar Keppler Gouras

Gunnar Keppler Gouras

Auto-generated profile, based on publicly available information

Gunnar Keppler Gouras

Experimental Dementia Research Unit, Department of Experimental Medical Science, Lund University, Lund, Sweden

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 July 2005 in Nature Neuroscience
Verified
Journal Article
Closed access
PDF file
ESEric M Snyder
Eric M Snyder
YNYi Nong
Yi Nong
Claudia Guimas AlmeidaClaudia Guimas Almeida
Claudia Guimas Almeida
SPSurojit Paul
Surojit Paul
TMTimothy Moran
Timothy Moran
PGPaul Greengard
Paul Greengard

1 January 2000 in The American Journal of Pathology
Verified
Journal Article
Open access
GGGunnar K. Gouras
Gunnar K. Gouras
JTJulia Tsai
Julia Tsai
JNJan Naslund
Jan Naslund
BVBruno Vincent
Bruno Vincent
MEMark Edgar
Mark Edgar
NRNorman R. Relkin
Norman R. Relkin
Alzheimer's disease (AD) is characterized by the deposition of senile plaques (SPs) and neurofibrillary tangles (NFTs) in vulnerable brain regions. SPs are composed of aggregated beta-amyloid (Abeta) 40/42(43) peptides. Evidence implicates a central role for Abeta in the pathophysiology of AD. Mutations in betaAPP and presenilin 1 (PS1) lead to elevated secretion of Abeta, especially the more amyloidogenic Abeta42. Immunohistochemical studies have also emphasized the importance of Abeta42 in initiating plaque pathology. Cell biological studies have demonstrated that Abeta is generated intracellularly. Recently, endogenous Abeta42 staining was demonstrated within cultured neurons by confocal immunofluorescence microscopy and within neurons of PS1 mutant transgenic mice. A central question about the role of Abeta in disease concerns whether extracellular Abeta deposition or intracellular Abeta accumulation initiates the disease process. Here we report that human neurons in AD-vulnerable brain regions specifically accumulate gamma-cleaved Abeta42 and suggest that this intraneuronal Abeta42 immunoreactivity appears to precede both NFT and Abeta plaque deposition. This study suggests that intracellular Abeta42 accumulation is an early event in neuronal dysfunction and that preventing intraneuronal Abeta42 aggregation may be an important therapeutic direction for the treatment of AD.

1 November 2002 in The American Journal of Pathology
Verified
Journal Article
Closed access
RTReisuke H. Takahashi
Reisuke H. Takahashi
TMTeresa A. Milner
Teresa A. Milner
FLFeng Li
Feng Li
ENEllen E. Nam
Ellen E. Nam
MEMark A. Edgar
Mark A. Edgar
GGGunnar K. Gouras
Gunnar K. Gouras

1 April 1998 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
HXHuaxi Xu
Huaxi Xu
GGGunnar K. Gouras
Gunnar K. Gouras
JGJeffrey P Greenfield
Jeffrey P Greenfield
BVBruno Vincent
Bruno Vincent
JNJan Naslund
Jan Naslund
SGSam Gandy
Sam Gandy

9 January 2003 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
FDFei Dou
Fei Dou
WNWilliam J. Netzer
William J. Netzer
KTKentaro Tanemura
Kentaro Tanemura
FLFeng Li
Feng Li
FHF. Ulrich Hartl
F. Ulrich Hartl
HXHuaxi Xu
Huaxi Xu
Molecular chaperones and their functions in protein folding have been implicated in several neurodegenerative diseases, including Parkinson's disease and Huntington's disease, which are characterized by accumulation of protein aggregates (e.g., α-synuclein and huntingtin, respectively). These aggregates have been shown in various experimental systems to respond to changes in levels of molecular chaperones suggesting the possibility of therapeutic intervention and a role for chaperones in disease pathogenesis. It remains unclear whether chaperones also play a role in Alzheimer's disease, a neurodegenerative disorder characterized by β-amyloid and tau protein aggregates. Here, we report an inverse relationship between aggregated tau and the levels of heat shock protein (Hsp)70/90 in tau transgenic mouse and Alzheimer's disease brains. In various cellular models, increased levels of Hsp70 and Hsp90 promote tau solubility and tau binding to microtubules, reduce insoluble tau and cause reduced tau phosphorylation. Conversely, lowered levels of Hsp70 and Hsp90 result in the opposite effects. We have also demonstrated a direct association of the chaperones with tau proteins. Our results suggest that up-regulation of molecular chaperones may suppress formation of neurofibrillary tangles by partitioning tau into a productive folding pathway and thereby preventing tau aggregation.

15 April 2001 in Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
LGLaura Gasparini
Laura Gasparini
GGGunnar K. Gouras
Gunnar K. Gouras
RWRong Wang
Rong Wang
RGRachel S. Gross
Rachel S. Gross
MBM. Flint Beal
M. Flint Beal
HXHuaxi Xu
Huaxi Xu
Alzheimer's Disease (AD) is characterized by cerebral accumulation of β-amyloid peptides (Aβ), which are proteolytically derived from β-amyloid precursor protein (βAPP). βAPP metabolism is highly regulated via various signal transduction systems, e.g., several serine/threonine kinases and phosphatases. Several growth factors known to act via receptor tyrosine kinases also have been demonstrated to regulate sβAPP secretion. Among these receptors, insulin and insulin-like growth factor-1 receptors are highly expressed in brain, especially in hippocampus and cortex. Emerging evidence indicates that insulin has important functions in brain regions involved in learning and memory. Here we present evidence that insulin significantly reduces intracellular accumulation of Aβ and that it does so by accelerating βAPP/Aβ trafficking from thetrans-Golgi network, a major cellular site for Aβ generation, to the plasma membrane. Furthermore, insulin increases the extracellular level of Aβ both by promoting its secretion and by inhibiting its degradation via insulin-degrading enzyme. The action of insulin on βAPP metabolism is mediated via a receptor tyrosine kinase/mitogen-activated protein (MAP) kinase kinase pathway. The results suggest cell biological and signal transduction mechanisms by which insulin modulates βAPP and Aβ trafficking in neuronal cultures.